By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806



Drug Discovery

Company News
BioInvent (BOVNF) Announces FDA Acceptance Of The Investigational New Drug Application For The Phase I/IIa Study With TB-403 1/7/2016 1:37:03 PM
BioInvent (BOVNF) Selected For Manufacturing Services By Global Pharmaceutical Company; Expects To Generate About SEK 25 Million In Revenue 12/17/2015 11:31:49 AM
BioInvent (BOVNF) Update On Clinical And Preclinical Drug Programs 12/16/2015 11:34:34 AM
BioInvent (BOVNF) In-Licenses Cutting Edge Technology To Pave The Way For More Efficacious Cancer Treatments 12/10/2015 11:12:33 AM
BioInvent (BOVNF) Interim Report 1 January – 30 September 2015 10/22/2015 11:30:54 AM
BioInvent (BOVNF) And The University of Pennsylvania Enhance Planned Clinical Study With BI-505 9/21/2015 11:36:45 AM
BioInvent (BOVNF) Interim Report 1 January – 30 June 2015 7/22/2015 10:37:45 AM
BioInvent (BOVNF) Progresses Collaboration With Leading U.S. Biotechnology Company 6/17/2015 11:14:05 AM
BioInvent (BOVNF): Management's Shareholding After Completion Of The Rights Issue 6/15/2015 1:29:48 PM
BioInvent (BOVNF) Enters Into Third Research Collaboration With University of Southampton 6/1/2015 11:17:46 AM